Purple Footprints
Expanding our Leadership Team
We are delighted to announce the expansion of our leadership team with the appointment of Dr Amber Johns as Head of Programs and Astrid Mallard as Head of Marketing.
Read story ➞Exciting Update to our 2024 Scientific Meeting Program
At the 2024 PanKind Scientific Meeting, we are introducing a new session to the program: Pancreatic Cancer New Concepts.
Read story ➞
Breakthrough in Pancreatic Cancer Detection: Unlocking Liquid Biopsy Potential
Pancreatic cancer, known for its aggressive nature and late-stage diagnosis, poses challenges in effective treatment and management. However, recent advancements in medical research may offer a glimmer of hope for early detection and improved outcomes for patients.
Read story ➞
Pancreatic Cancer Care: Promising Results of Investigational mRNA Vaccine
An investigational mRNA vaccine known as autogene cevumeran has demonstrated some potential in improving treatment outcomes for patients. The latest findings, presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, shed light on the promising immune response elicited by this innovative vaccine.
Read story ➞